Abstract
Squamous carcinoma of the upper aerodigestive tract comprises 5% of new cancer cases each year and accounts for 12000–15000 deaths. It is estimated that over 30000 new cases of oral cavity and pharynx cancer occur each year (Silverberg et al. 1990). Two thirds of these will be advanced (stage III or IV) at time of diagnosis. Conventional treatment strategies for these patients consist of combinations of radical surgical resection and postoperative radiation therapy and are associated with dismal 3-year survival rates ranging from 0%–50%. Furthermore, these treatment approaches result in significant functional and cosmetic disabilities due to radical resections of the tongue, mandible, pharynx, and larynx. Despite continuing refinements in surgical reconstruction, cancers arising in the oral cavity and pharynx consistently result in significant impairments in speech and swallowing that seriously affect quality of life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Al-Kourainy K, Kish J, Ensley J et al. (1987) Achievement of superior survival for histologically negative versus histologically positive complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 99: 233–238
Al-Sarraf M, Scott CB, Ahmad K et al. (1992) Phase III study comparing sequential chemotherapy and radiotherapy to radiotherapy for resected and negative margins in squamous cell carcinoma of the head and neck: intergoup study #0034. Proc Am Soc Clin Oncol 11: 242
Clark J, Busse P, Norris C et al. (1991) Regional control after induction therapy for head and neck cancer: an analysis of 303 patients and a proposal for management of the neck. Proc Am Soc Clin Oncol 10: 197
Croll GA, Gerritson GJ, Tiwari RS et al. (1989) Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma: results and complications. Eur J Surg Oncol 15: 350–356
Decker DA, Drelichman A, Jacobs J et al. (1983) Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Cancer 60: 301–311
Department of Veterans ’ Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324: 1685–1690
Ensley JF, Jacobs JR, Weaver A et al. (1984) Correlation between response to cisplatin-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54: 811–814
Ervin TJ, Kirkwood J, Weichiselbaum RR et al. (1981) Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery. Laryngoscope 91: 1181–1190
Ervin TS, Clark JR, Weichselbaum RR et al. (1987) An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous cell carcinoma of the head and neck. J Clin Oncol 5: 10–20
Harwood AR, Bryce DP, Rider WO (1980) Management of T3 glottic cancer. Arch Otolaryngol 106: 697–699
Harwood AR, ENT Group (1982) The management of advanced supraglottic carci-noma by delayed combined therapy. Int J Radiat Oncol Biol Phys 8:101–102 Harwood AR, Bealer FA, Cummings BJ (1983) Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients. Int J Radiat Oncol Biol Phys 9: 311–319
Head and Neck Contracts Program (1987) Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Cancer 60: 301–311
Holoye PY, Grossman TW, Toohill RJ. (1985) Randomized study of adjuvant chemotherapy for head and neck cancer. Otolaryngol Head Neck Surg 93:712–715 Hong WK, O ’Donoghue GM, Sheetz S et al. (1985) Sequential response patterns to chemotherapy and radiotherapy in head and neck cancer: potential impact to treatment in advanced laryngeal cancer. Prog Oncol Res 201: 191–197
Hong WK, O’Donoghue GM, Sheetz S et al. (1985) Sequential response patterns to chemotherapy and radiotherapy in head and neck cancer: potential impact to treatment in advanced laryngeal cancer. Prog Oncol Res 201: 191–197
Jacobs C, Goffinet DR, Goffinet L et al. (1987) Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. Cancer 60: 1178–1183
Karp D, Carter R, Vaugh C. (1988) Voice preservation using induction chemotherapy
plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer long term follow-up. Proc Am Soc Clin Oncol 7:152
Kies MS, Gordan LI, Hauck WW et al. (1985) Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer. Otolaryngol Head Neck Surg 93: 199–205
Kish J, Drechman A, Peppard S et al. (1982) Clinical trial of cisplatin and 5-fluorouracil as initial treatment of advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 66: 471–474
Kish J, Ensley JF, Tapazoglou E, Al-Saraf M (1989) Carboplatin and 5-FU infusion as an effective outpatient induction chemotherapy in patients with locally advanced head and neck cancer. Proc Am Soc Clin Oncol 8: 173
Martin M, Hazan A, Vergnes L et al. (1990) Randomized study of 5-fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: a preliminary report. Int J Radiat Oncol Biol Phys 19: 973–975
Pfister DG, Harrison L, Strong EW et al. (1992) Organ/function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. Proc Am Soc Clin Oncol 11: 241
Pinto HA, Jacobs C, van Der Pas M et al. (1991) Long-term follow-up of organ preservation in advanced resectable head and neck cancer. Proc Am Soc Clin Oncol 10: 207
Schuller DE, Metch B, Stein DW et al. (1988) Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the southwest oncology group. Laryngoscope 98: 1205–1211
Silverberg E, Boray CC, Squires TS (1990) Cancer statistics. Cancer 40: 9–26
Tarpley JL, Chretien PB, Alexander JC et al. (1975) High dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck. Am J Surg 130: 481–486
Taylor SG, Applebaum E, Showel JL et al. (1985) A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 3: 672–679
Toohill RJ, Anderson T, Byhardt RW et al. (1987) Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. Arch Otolaryngol Head Neck Surg 113: 758–761
Urba SG, Forastiere AA, Wolf GT et al. (1989) Neoadjuvant chemotherapy with high dose continuous infusion cisplatin, 5-fluorouracil and mitoguazone for head and neck cancer. Proc Am Soc Clin Oncol 8: 172
Urba SG, Wolf GT, McLaughlin P, Hazuka M (1992) Neoadjuvant carboplatin, 5-fluorouracil and radiation therapy for organ preservation in patients with resectable advanced head and neck cancer. 3rd international conference on head neck cancer, San Francisco, July 1992
Vokes EE, Schulsky RL, Weichselbaum RR et al. (1990) Induction chemotherapy with cisplatin, fluorouracil and high dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 8: 241–247
Volling P, Schroder M, Rausching W et al. (1989) Carboplatin: the better platinum in head and neck cancer. Arch Otolaryngol Head Neck Surg 115: 695–698
Weaver A, Flemming S, Kish J et al. (1982) Cisplatin and 5-fluorouracil as induction therapy for advanced head and neck cancer. Am J Surg 144: 445–448
Wolf GT (1984) An overview of preoperative chemotherapy: where do we go from here? Am J Otolaryngol 5: 77–79
Wolf GT, Fisher SG (1992) Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 102:(in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wolf, G.T., Urba, S., Hazuka, M. (1994). Induction Chemotherapy for Organ Preservation in Advanced Squamous Cell Carcinoma of the Oral Cavity and Oropharynx. In: Pape, HD., Ganzer, U., Schmitt, G. (eds) Carcinoma of the Oral Cavity and Oropharynx. Recent Results in Cancer Research, vol 134. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84971-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-84971-8_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84973-2
Online ISBN: 978-3-642-84971-8
eBook Packages: Springer Book Archive